Rowland & CO Investment Counsel Merck & Co., Inc. Transaction History
Rowland & CO Investment Counsel
- $468 Million
- Q1 2025
A detailed history of Rowland & CO Investment Counsel transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rowland & CO Investment Counsel holds 40,698 shares of MRK stock, worth $3.21 Million. This represents 0.78% of its overall portfolio holdings.
Number of Shares
40,698
Previous 42,548
4.35%
Holding current value
$3.21 Million
Previous $4.23 Million
13.68%
% of portfolio
0.78%
Previous 0.9%
Shares
28 transactions
Others Institutions Holding MRK
# of Institutions
3,897Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$19.9 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.3 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.5 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.44 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.7 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $200B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...